Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

VCAM-1 serum levels are associated with arthropathy in hereditary haemochromatosis.

Nell-Duxneuner V, Axmann R, Husar-Memmer E, Dallos T, Datz C, Stadlmayr A, Aigner E, Englbrecht M, Schett G, Zwerina J.

Ann Rheum Dis. 2013 Dec;72(12):2006-10. doi: 10.1136/annrheumdis-2012-202800. Epub 2013 Apr 18.

PMID:
23599437
2.

Idiopathic hand osteoarthritis vs haemochromatosis arthropathy--a clinical, functional and radiographic study.

Dallos T, Sahinbegovic E, Stamm T, Aigner E, Axmann R, Stadlmayr A, Englbrecht M, Datz C, Schett G, Zwerina J.

Rheumatology (Oxford). 2013 May;52(5):910-5. doi: 10.1093/rheumatology/kes392. Epub 2013 Jan 12.

PMID:
23315789
3.

Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.

Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, Jakobsson PJ, Baum W, Nimmerjahn F, Szarka E, Sarmay G, Krumbholz G, Neumann E, Toes R, Scherer HU, Catrina AI, Klareskog L, Jurdic P, Schett G.

J Clin Invest. 2012 May;122(5):1791-802. doi: 10.1172/JCI60975. Epub 2012 Apr 16.

4.

RSK2 protects mice against TNF-induced bone loss.

Böhm C, Derer A, Axmann R, Hillienhoff U, Zaiss MM, Luther J, Zech C, Stock M, Scholtysek C, Engelke K, Hess A, Tuckermann JP, Schett G, David JP.

J Cell Sci. 2012 May 1;125(Pt 9):2160-71. doi: 10.1242/jcs.096008. Epub 2012 Feb 17.

5.

Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis.

Beyer C, Axmann R, Sahinbegovic E, Distler JH, Manger B, Schett G, Zwerina J.

Ann Rheum Dis. 2011 Oct;70(10):1874-5. doi: 10.1136/ard.2010.149351. Epub 2011 Apr 24. No abstract available.

PMID:
21515917
6.

Vitamin D receptor regulates TNF-mediated arthritis.

Zwerina K, Baum W, Axmann R, Heiland GR, Distler JH, Smolen J, Hayer S, Zwerina J, Schett G.

Ann Rheum Dis. 2011 Jun;70(6):1122-9. doi: 10.1136/ard.2010.142331. Epub 2011 Mar 17.

PMID:
21415051
7.

Blockade of TNF-α rapidly inhibits pain responses in the central nervous system.

Hess A, Axmann R, Rech J, Finzel S, Heindl C, Kreitz S, Sergeeva M, Saake M, Garcia M, Kollias G, Straub RH, Sporns O, Doerfler A, Brune K, Schett G.

Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3731-6. doi: 10.1073/pnas.1011774108. Epub 2011 Jan 18.

8.

Musculoskeletal disease burden of hereditary hemochromatosis.

Sahinbegovic E, Dallos T, Aigner E, Axmann R, Manger B, Englbrecht M, Schöniger-Hekele M, Karonitsch T, Stamm T, Farkas M, Karger T, Stölzel U, Keysser G, Datz C, Schett G, Zwerina J.

Arthritis Rheum. 2010 Dec;62(12):3792-8. doi: 10.1002/art.27712.

9.

Validation of a radiographic scoring system for haemochromatosis arthropathy.

Dallos T, Sahinbegovic E, Aigner E, Axmann R, Schöniger-Hekele M, Karonitsch T, Stamm T, Farkas M, Karger T, Cavallaro A, Stölzel U, Keysser G, Datz C, Schett G, Manger B, Zwerina J.

Ann Rheum Dis. 2010 Dec;69(12):2145-51. doi: 10.1136/ard.2009.122119. Epub 2010 Aug 2.

PMID:
20679473
10.

Hereditary hemochromatosis as a risk factor for joint replacement surgery.

Sahinbegovic E, Dallos T, Aigner E, Axmann R, Engelbrecht M, Schöniger-Hekele M, Karonitsch T, Farkas M, Karger T, Willeit J, Stölzel U, Keysser G, Datz C, Kiechl S, Schett G, Zwerina J.

Am J Med. 2010 Jul;123(7):659-62. doi: 10.1016/j.amjmed.2010.01.024.

PMID:
20609690
11.

Risk prediction for severe osteoarthritis.

Schett G, Zwerina J, Axmann R, Willeit J, Stefan K.

Ann Rheum Dis. 2010 Aug;69(8):1573-4. doi: 10.1136/ard.2009.123661. Epub 2010 Apr 13. No abstract available.

PMID:
20388743
12.

Combining functional magnetic resonance imaging with mouse genomics: new options in pain research.

Heindl-Erdmann C, Axmann R, Kreitz S, Zwerina J, Penninger J, Schett G, Brune K, Hess A.

Neuroreport. 2010 Jan 6;21(1):29-33. doi: 10.1097/WNR.0b013e3283324faf.

PMID:
19934782
13.

Pathogenesis of Churg-Strauss syndrome: recent insights.

Zwerina J, Axmann R, Jatzwauk M, Sahinbegovic E, Polzer K, Schett G.

Autoimmunity. 2009 May;42(4):376-9. Review.

PMID:
19811306
14.

Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.

Axmann R, Böhm C, Krönke G, Zwerina J, Smolen J, Schett G.

Arthritis Rheum. 2009 Sep;60(9):2747-56. doi: 10.1002/art.24781.

15.

12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis.

Krönke G, Katzenbeisser J, Uderhardt S, Zaiss MM, Scholtysek C, Schabbauer G, Zarbock A, Koenders MI, Axmann R, Zwerina J, Baenckler HW, van den Berg W, Voll RE, Kühn H, Joosten LA, Schett G.

J Immunol. 2009 Sep 1;183(5):3383-9. doi: 10.4049/jimmunol.0900327. Epub 2009 Aug 12.

16.

Vascular cell adhesion molecule 1 as a predictor of severe osteoarthritis of the hip and knee joints.

Schett G, Kiechl S, Bonora E, Zwerina J, Mayr A, Axmann R, Weger S, Oberhollenzer F, Lorenzini R, Willeit J.

Arthritis Rheum. 2009 Aug;60(8):2381-9. doi: 10.1002/art.24757.

17.

The emergence of antineutrophil cytoplasmic antibodies may precede the clinical onset of Churg-Strauss syndrome.

Zwerina J, Axmann R, Manger B, Schett G.

Arthritis Rheum. 2009 Feb;60(2):626-7. doi: 10.1002/art.24285. No abstract available.

18.

Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis.

Akhmetshina A, Dees C, Pileckyte M, Maurer B, Axmann R, Jüngel A, Zwerina J, Gay S, Schett G, Distler O, Distler JH.

FASEB J. 2008 Jul;22(7):2214-22. doi: 10.1096/fj.07-105627. Epub 2008 Mar 7.

PMID:
18326784
19.

CTLA-4 directly inhibits osteoclast formation.

Axmann R, Herman S, Zaiss M, Franz S, Polzer K, Zwerina J, Herrmann M, Smolen J, Schett G.

Ann Rheum Dis. 2008 Nov;67(11):1603-9. doi: 10.1136/ard.2007.080713. Epub 2008 Jan 18.

PMID:
18203760
20.

Treg cells suppress osteoclast formation: a new link between the immune system and bone.

Zaiss MM, Axmann R, Zwerina J, Polzer K, Gückel E, Skapenko A, Schulze-Koops H, Horwood N, Cope A, Schett G.

Arthritis Rheum. 2007 Dec;56(12):4104-12.

Supplemental Content

Loading ...
Support Center